Will Oscar Health report Q1 2026 paid membership above 2.7 million?

Management targets 3.0M paid members, and the question asks about 2.7M — a significantly lower bar. Oscar would need to lose 700K of 3.4M enrolled (21%) to miss this threshold. Management's expectation of 400K churn implies 3.0M, and even a 50% overshoot in churn (600K) would still leave 2.8M above the threshold. The market contraction is tracking toward the lower end (5% so far vs 20-30% expected). The 2.7M threshold is deliberately conservative, requiring a catastrophic scenario to miss.

The gap between the 3.4M enrolled and 2.7M threshold provides a 700K buffer. Oscar's expected churn of 400K would leave 3.0M, meaning an additional 300K beyond expectations would need to churn. However, grace periods extend through Q1, meaning some of the churn may be delayed into Q2. The question is whether the subsidy cliff causes dramatically more churn than the 400K forecast. Given that market contraction is tracking 5% (lower end), and Oscar proactively priced for subsidy expiration, the probability of holding above 2.7M is meaningfully above 50%.

Management is experienced at enrollment forecasting even if profitability forecasting has been unreliable. The 3.0M target accounts for 400K churn, and the 2.7M threshold requires double that churn. Oscar's competitive positioning — affordable bronze/gold plans, 60% broker expansion — should provide retention advantages. However, I discount slightly for the possibility that the subsidy cliff impact accelerates in late Q1 as grace periods expire and the full 20-30% market contraction materializes faster than expected.

The 2.7M bar is set well below the 3.0M target. Oscar would need to see 700K churn — 75% more than their 400K expectation. This seems unlikely given that current market data shows only 5% contraction. Oscar's proactive pricing for subsidy expiration and affordable product design provide retention advantages. The enrollment figure of 3.4M itself suggests strong demand.

While the threshold provides buffer, I'm cautious about the tail risk. The grace period masking churn means we don't know the true picture yet. If health care costs are now the 'single largest family budget item' per the CEO, the transition from $0 premium to paid could trigger cascading non-payment beyond the initial 400K estimate. The 12% non-payment rate implied in enrollment data is already high. Still above 60% for YES, but the uncertainty is real.

The question essentially asks whether Oscar loses more than 20% of enrolled members. Even in the worst-case subsidy cliff scenario (30% market contraction), Oscar's positioned better than peers — they priced for expiration and designed affordable products. The 2.7M threshold accounts for almost the full 30% market contraction scenario. Lean YES at about two-thirds probability.

3.4M enrolled, 3.0M expected, 2.7M threshold. The buffer is large. Market contraction at 5% is mild so far. Oscar priced for subsidy expiration. Strong lean toward YES.

The 2.7M threshold is conservative enough that it would require a significantly worse-than-expected outcome to miss. Management's 400K churn estimate leaves a 300K buffer above 2.7M. Even with uncertainty, probability above 65%.

Simple math: 3.4M enrolled minus 400K expected churn = 3.0M. Need to drop to 2.7M, meaning 300K additional churn beyond expectations. Possible but unlikely given current data showing only 5% market contraction. Lean YES at approximately 70%.